Locus Biosciences is a precision medicine company that focuses on developing bacteriophage-based products. These products are designed to precisely remove pathogenic bacteria from the human body and harness the power of the microbiome to treat diseases across multiple therapeutic areas. With the rise of antibiotic resistance, there is a pressing need for new approaches in healthcare.

Locus Biosciences aims to address this challenge by targeting only the specific bacteria causing an infection, leaving the rest of the microbiome unaffected. By doing so, they minimize disruptions to the natural balance of bacteria in the body, reducing the risk of side effects and secondary problems. In addition to combating infections, Locus Biosciences is also developing biotherapeutics that utilize the microbiome to treat common diseases, such as inflammatory bowel disease and cancer.

With a team of experienced leaders in precision antibacterial drug development, Locus Biosciences is pushing the boundaries of medicine to create more precise and effective treatments